INO Overview
Upcoming Projects (INO)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (INO)
-
Electroporation Expert Interview: An Overview and its Pharmaceutical Potential
Tickers: INO, PFE, RHHBY, ROLL
Execute By: Nov 02, 2016
Included with Membership
Upcoming & Overdue Catalysts (INO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (INO)
-
INOVIO (INO) Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
Ticker: INO
Occurred on: Sep 28, 2020 -
Inovio's (INO) HIV Vaccine PENNVAX-GP Phase 1 data analysis released
Ticker: INO
Occurred on: May 15, 2018 -
Inovio Pharma (INO) to start Phase 1 study of INO-5400, a new multi-antigen cancer immunotherapy and checkpoint inhibitor, in late 2016
Ticker: INO
Occurred on: Nov 16, 2017 -
INO-3112 Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Ticker: INO
Occurred on: Nov 14, 2016 -
FDA Delays Initiation of Inovio's (INO) Phase 3 Program Evaluating VGX-3100 in HPV-Related Cancers, Requests Additional Information
Ticker: INO
Occurred on: Oct 24, 2016 -
Inovio Pharma to initiate Phase 3 trial of VGX-3100 for HPV-related cervical dysplasia in Q3 2016
Ticker: INO
Occurred on: Oct 24, 2016 -
Inovio Pharma (INO) to complete Phase 2 trial of VGX-3100 for HPV-related cervical dysplasia in Q2 2016
Ticker: INO
Occurred on: May 09, 2016 -
Inovio Pharma (INO) completes acquisition of Bioject Medical Technologies for 5.5MM
Ticker: INO
Occurred on: Mar 14, 2016
Strategic Initiatives (INO)
-
QIAGEN(QGEN) and Inovio(INO) to collaborate on liquid biopsy companion diagnostic
Tickers: INO, QGEN
Announcement Date: May 16, 2019
